Recent Trends in the Use of “Club Drugs”: An Australian Review
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis Ltd in Substance Use & Misuse
- Vol. 40 (9-10), 1241-1256
- https://doi.org/10.1081/ja-200066777
Abstract
The use of “club drugs” such as MDMA, ketamine, and GHB appears to have increased in Western countries over the last 20 years, and Australia is no exception to that trend. While levels of use appear to be relatively low in the general population, among users of these drugs a number of adverse health and psychological problems, including dependence, have been reported. MDMA or ecstasy is the third most commonly used illicit drug in Australia, and relatively more information is available on its use in Australia than of drugs such as GHB or ketamine. Although there are no population level data available, levels of ketamine use in the general population appear to be lower than those of MDMA. In addition, the harms reported by recreational users are not excessive and the mortality rate is low. At the individual level, many of those who experiment find the effects aversive and do not persist. The harms that require further investigation are the association between ketamine and unsafe sex and injecting behaviors, the neurotoxic effects, and use in situations where there is a heightened risk of accidental death when the user's cognition is grossly impaired. In contrast, while least is known of the epidemiology of GHB use, there is mounting evidence suggesting significant acute and long-term risks associated with the use of this drug. This suggests an urgent need for international research on the patterns of use, health, and psychosocial consequences of GHB use. In order to address public health issues associated with a range of club drug use, there is a need for research to identify the trends in population prevalence of these drugs. This could be most easily achieved by the inclusion of MDMA, ketamine, and GHB in household surveys that are currently collected routinely in a number of countries.Keywords
This publication has 62 references indexed in Scilit:
- Hyponatremia Associated with 3,4-Methylenedioxymethylamphetamine (“Ecstasy”) AbuseThe American Journal of the Medical Sciences, 2003
- Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern SpainEuropean Addiction Research, 2002
- In and out of the K‐hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine usersAddiction, 2001
- Successful Management of Prolonged γ-Hydroxybutyrate and Alcohol WithdrawalPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Gamma Butyrolactone (GBL) Withdrawal SyndromesPsychosomatics, 2001
- Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days laterAddiction, 2000
- Severe gamma-hydroxybutyrate withdrawal: a case report and literature reviewThe Journal of Emergency Medicine, 2000
- Substance use among young people: the relationship between perceived functions and intentionsAddiction, 1999
- MDMA and Human Sexual FunctionJournal of Psychoactive Drugs, 1986
- Abuse of KetamineThe British Journal of Psychiatry, 1980